2026-04-25T08:17:48Z https://www.pub.unibl.org/oai

oai:pub.unibl.org:30875 2025-12-19T04:43:51Z

Sorafenib as first line treatment for advanced liver cancer - are expiries /unibl/sci/idNaucniRad:25647 Conference Paper text 2012 Z. Gojković, S. Jungić, I. Rakita, Ž. Vranješ, R. Rašeta, G. Marić, M. Vještica, S. Mijatović, P. Dašić, M. Vižin, J. Rožić, Sorafenib as first line treatment for advanced liver cancer - are expiries, Annals of Oncology 2012; 23(4) iv57, 2012 Annals of Oncology Annals of Oncology 2012; 23(4) iv57 https://www.unibl.org/sr-lat/fis/zaposlen/3371-zdenka-gojkovic https://www.unibl.org/sr-lat/fis/zaposlen/3512-sasa-jungic /unibl/author/Ivanka Rakita /unibl/author/Živko Vranješ /unibl/author/Radmila Rašeta /unibl/author/G. Marić /unibl/author/M. Vještica /unibl/author/S. Mijatović /unibl/author/P. Dašić /unibl/author/M. Vižin /unibl/author/Jelena Rožić Annals of Oncology Annals of Oncology 2012; 23(4) iv57 https://www.unibl.org/sr-lat/fis/zaposlen/3371-zdenka-gojkovic https://www.unibl.org/sr-lat/fis/zaposlen/3512-sasa-jungic /unibl/author/Ivanka Rakita /unibl/author/Živko Vranješ /unibl/author/Radmila Rašeta /unibl/author/G. Marić /unibl/author/M. Vještica /unibl/author/S. Mijatović /unibl/author/P. Dašić /unibl/author/M. Vižin /unibl/author/Jelena Rožić https://www.pub.unibl.org/s/cir/item/30875